Derivatives of 4-(2′-Methoxyphenyl)-1-[2′-(N-2″-pyridinyl-p-iodobenzamido)ethyl]piperazine (p-MPPI) as 5-HT1A Ligands

Journal of Medicinal Chemistry

Volumn 37, Issue 26, 1994, Pages 4572-4575

  Zhuang, Zhi Ping ^a,b   Kung, Mei Ping ^a,b   Chumpradit, Sumalee ^a,b   Mu, Mu ^a,b   Kung, Hank F ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Departments of Radiology   (United States)

^c Pharmacology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 [4 AZIDO 3 IODO N (2 PYRIDYL)BENZAMIDO]ETHYL] 4 (2 METHOXYPHENYL)PIPERAZINE; 1 [2 [4 IODO N (2 PYRIDYL)BENZAMIDO]ETHYL] 4 (2 METHOXYPHENYL)PIPERAZINE; ALKYLATING AGENT; PIPERAZINE DERIVATIVE; SEROTONIN; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HIPPOCAMPUS; NONHUMAN; PHOTOAFFINITY LABELING; RAT; STRUCTURE ACTIVITY RELATION;

AFFINITY LABELS; AMINOPYRIDINES; ANIMAL; HIPPOCAMPUS; LIGANDS; PIPERAZINES; RATS; RECEPTORS, SEROTONIN; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028600122     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00052a018     Document Type: Article

References (28)

1. Frazer, A.; Maayani, S.; Wolfe, B. B. Subtypes of Receptors For Serotonin. Ann. Rev. Pharm. Toxicol. 1990, 30, 307-348
2. Frazer, A.; Hensler, J. G. 5-HT1A Receptors and 5-HT1A-Mediated Responses: Effect of Treatments That Modify Serotonergic Neurotransmission. Ann. N.Y. Acad. Sci. 1990, 600, 460-475
3. Hartig, P. R.; Adham, N.; Zgombick, J.; Macchi, M.; Kao, H. T.; Schechter, L.; Branchek, T.; Weinshank, R. Serotonin Receptor Subtypes. Psychopharm. Ser. 1993, 10, 15-25
4. Hamon, M.; Lanfumey, L.; El Mestikawy, S.; Boni, C.; Miquel, M. -C.; Bolanos, F.; Schechter, L.; Gozlan, H. The Main Features of Central 5-HT1 Receptors. Neuropsychopharmacology 1990, 3, 349-360
5. Radja, F.; Daval, G.; Hamon, M.; Verge, D. Pharmacological and Physicochemical Properties of Presynaptic Versus Postsynaptic 5-Hydroxytryptamine-1A Receptor Binding Sites In the Rat Brain: A Quantitative Autoradiographic Study. J. Neurochem. 1992, 58, 1338-1346
6. Cliffe, I. A.; Brightwell, C. I.; Fletcher, A.; Forster, E. A.; Mansell, H. L.; Reilly, Y.; Routledge, C.; White, A. C. (S)-N-Tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: A Selective Antagonist At Presynaptic and Postsynaptic 5-HT1A Receptors. J. Med. Chem. 1993, 36, 1509-1510
7. Hillver, S. E.; Bjork, L.; Li, Y. L.; Svensson, B.; Ross, S.; Anden, N. E.; Hacksell, U. (S)-5-Fluoro-8-hydroxy-2-(dipropylamino) tetralin: A Putative 5-HT1A-Receptor Antagonist [letter]. J. Med. Chem. 1990, 33, 1541-1544
8. Glennon, R. A.; Naiman, N. A.; Lyon, R. A.; Titeler, M. Arylpiperazine Derivatives As High-Affinity 5-HT1A Serotonin Ligands. J. Med. Chem. 1988, 31, 1968-1971
9. Raghupathi, R. K.; Rydelek-Fitzgerald, L.; Teitler, M.; Glennon, R. A. Analogues of the 5-HT1A Serotonin Antagonist 1-(2- Methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine With Reduced Alpha-Adrenergic Affinity. J. Med. Chem. 1991, 34, 2633-2638
10. Glennon, R. A.; Naiman, N. A.; Pierson, M. E.; Smith, J. D.; Ismaiel, A. M.; Titeler, M.; Lyon, R. A. N-(Phthalimidoalkyl) Derivatives of Serotonergic Agents: A Common Interaction At 5-HT1A Serotonin Binding Sites? J. Med. Chem. 1989, 32, 1921-1926
11. Glennon, R. A.; Westkaemper, R. B.; Bartyzel, P. Medical Chemistry of Serotonergic Agents. In Receptor Biochemistry and Methodology; Peroutka, S. J., Ed.; Wiley-Liss: Stanford, CA, 1991; pp 19-64
12. Greuel, J. M.; Glaser, T. The Putative 5-HT1A Receptor Antagonists NAN-190 and BMY 7378 Are Partial Agonists In the Rat Dorsal Raphe Nucleus In Vitro. Eur. J. Pharmacol. 1992, 211, 211-219
13. van Steen, B. J.; van Wijngaarden, I.; Tulp, M. T. M.; Soudijn, W. Structure-Affinity Relationship Studies on 5-HT1A Receptor Ligands. 2. Heterobicyclic Phenylpiperazines with N4-Aralkyl Substituents. J. Med. Chem. 1994, 37, 2761-2773
14. Kuipers, W.; van Wijngaarden, I.; Ijzerman, A. P. A Model of the Serotonin 5-HT1A Receptor: Agonist and Antagonist Binding Sites. Drug Des. Disc. 1994, 11, 231-249
15. Hacksell, U.; Liu, Y.; Yu, H.; Vallgärda, J.; Höök, B. B.; Johansson, A. M.; Lewander, T. Neuromedicinal Chemistry of 5-HT1A-Receptor Agonists and Antagonists. Drug Des. Discovery 1993, 9, 287-297
16. Hoyer, D.; Engel, G.; Kalkman, H. O. Molecular Pharmacology of 5-HT1 and 5-HT2 Recognition Sites In Rat and Pig Brain Membranes: Radioligand Binding Studies With [3H]5-HT, [3H]8-OHDPAT, (-)[125I]Iodocyanopindolol, [3H]Mesulergine and [3H]Ketanserin. Eur. J. Pharmacol. 1985, 118, 13-23
17. Hoyer, D. The 5-HT Receptor Family: Ligands, Distribution and Receptor-Effector Coupling. In 5-HT1A Agonists, 5-HT3 Antagonists and Benzodiazepines; Their Comparative Behavioural Pharmacology, Rodgers, R. J., Cooper, S. J., eds.; John Wiley & Sons: New York, 1991; pp 31-57
18. Rydelek-Fitzgerald, L.; Teitler, M.; Fletcher, P. W.; Ismaiel, A. M.; Glennon, R. A. NAN-190: Agonist and Antagonist Interactions With Brain 5-HT1A Receptors. Brain Res. 1990, 532, 191-196
19. Fletcher, A.; Bill, D. J.; Bill, S. J.; Cliffe, I. A.; Dover, G. M.; Forster, E. A.; Haskins, J. T.; Jones, D.; Mansell, H. L.; Reilly, Y. WAY100135: A Novel, Selective Antagonist At Presynaptic and Postsynaptic 5-HT1A Receptors. Eur. J. Pharmacol. 1993, 237, 283-291
20. Cliffe, I. A.; Brightwell, C. I.; Fletcher, A.; Forster, E. A.; Mansell, H. L.; Reilly, Y.; Routledge, C.; White, A. C. The Design of Selective 5-HT1A Receptor Antagonists. 206th ACS Meeting; American Chemical Society: Washington, DC, 1994; MEDI, Abstr. No. 30
21. Fletcher, A.; Cliffe, I. A.; Dourish, C. T. Silent 5-HT1A Receptor Antagonists: Utility As Research Tools and Therapeutic Agents. Trends Pharmacol. Sci. 1993, 14, 441-448
22. Zhuang, Z.-P.; Kung, M.-P.; Kung, H. F. Synthesis and Evaluation of 4-(2′-Methoxy-)phenyl-1-[2′-(N-2″-pyridinyl-)p-iodobenzamido-lethyl-piperazine (p-MPPI): A New Iodinated 5-HT1A Ligand. J. Med. Chem. 1994, 37, 1406-1407
23. Kung, H. F.; Kung, M.-P.; Clarke, W.; Maayani, S.; Zhuang, Z. -P. A Potential 5-HT1A Receptor Antagonist: p-MPPI. Life Sci. 1994, 55, 1459-1462
24. Zhuang, Z. P.; Kung, M. P.; Kung, H. F. Synthesis of (R,S)trans-8-Hydroxy-2-(N-n-propyl-N-3′-iodo-2′-propenyl)aminotetralin (trans-8-OH-PIPAT): A New 5-HT1A Receptor Ligand. J. Med. Chem. 1993, 36, 3161-3165
25. Radja, F.; Daval, G.; Emerit, M. B.; Gallissot, M. C.; Hamon, M.; Verge, D. Selective Irreversible Blockade of 5-hydroxytryptaminelA and 5-hydroxytryptaminelC Receptor Binding Sites in the Rat Brain By 8-MeO-2′-chloro-PAT: A Quantitative Autoradiographic Study. Neuroscience 1989, 31, 723-733
26. Bolanos, F. J.; Schechter, L. E.; Laporte, A. M.; Hamon, M.; Gozlan, H. Recovery of 5-HT1A Receptors After Irreversible Blockade By N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Proc. West. Pharmacol. Soc. 1991, 34, 387-393
27. Gozlan, H.; Ponchant, M.; Daval, G.; Verge, D.; Menard, F.; Vanhove, A.; Beaucourt, J. P.; Hamon, M. 125I-Bolton-Hunter-8-methoxy-2[n-propyl-n-propylamino]tetralin as a New Selective Radioligand of 5-HT1A Sites in the Rat Brain -In Vitro Binding and Autoradiographic Studies. J. Pharmacol. Exp. Ther. 1988, 244, 751-759
28. Munson, P.; Rodbard, D. LIGAND: A Versatile Computerized Approach for Characterization of Ligand-Binding Systems. Anal. Biochem. 1980, 107, 220-239